Literature DB >> 1806480

Metabolic effects of hypopituitarism and acromegaly.

P H Sönksen1, F Salomon, R Cuneo.   

Abstract

Hypopituitarism is associated with reduced lean body mass and increased body fat, while in acromegaly the converse is true. Fasting plasma glucose is increased in acromegaly but fasting plasma insulin and C-peptide are increased in both groups. There is a positive association between fat mass and fasting serum insulin in hypopituitarism, suggesting insulin resistance. Hypoglycaemia unresponsiveness, rather than insulin sensitivity, is the feature of growth hormone deficiency. Basal metabolic rate (expressed per kg body weight) is increased in acromegaly and decreased in hypopituitarism but when expressed 'per kg lean body mass', is increased in both groups. There is a close correlation between fat mass and fasting free fatty acid and glycerol levels in obese but not normal weight patients with hypopituitarism; slim patients appear to metabolise and oxidise their fat stores more effectively than those who remain obese. Thus indirect evidence suggests that growth hormone has an important role in maintaining normal body composition and energy stores.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1806480     DOI: 10.1159/000182184

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  3 in total

1.  SOCS2 negatively regulates growth hormone action in vitro and in vivo.

Authors:  Christopher J Greenhalgh; Elizabeth Rico-Bautista; Mattias Lorentzon; Anne L Thaus; Phillip O Morgan; Tracy A Willson; Panagiota Zervoudakis; Donald Metcalf; Ian Street; Nicos A Nicola; Andrew D Nash; Louis J Fabri; Gunnar Norstedt; Claes Ohlsson; Amilcar Flores-Morales; Warren S Alexander; Douglas J Hilton
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

2.  Protein tyrosine phosphatase 1B attenuates growth hormone-mediated JAK2-STAT signaling.

Authors:  Feng Gu; Nadia Dubé; Jin Wook Kim; Alan Cheng; Maria de Jesus Ibarra-Sanchez; Michel L Tremblay; Yves R Boisclair
Journal:  Mol Cell Biol       Date:  2003-06       Impact factor: 4.272

3.  Comparative Analysis of Human Growth Hormone in Serum Using SPRi, Nano-SPRi and ELISA Assays.

Authors:  Stephen Vance; Effat Zeidan; Vincent C Henrich; Marinella G Sandros
Journal:  J Vis Exp       Date:  2016-01-07       Impact factor: 1.355

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.